If currently deferred due to active side effects or recent treatment initiation, you may become eligible once: You have been on a stable Wegovy dose for several months without significant adverse effects Your weight and overall health meet donation criteria (minimum weight of 50 kg, stable blood pressure, good venous access) Any obesity-related comorbidities are well-controlled Maintain contact with your local donation centre and ask about reassessment timelines
Best practices include adaptive risk checks, optional biometric sign-in on mobile, and clear recovery paths
A comprehensive review on infant formula: nutritional and functional constituents, recent trends in processing and its impact on infants gut microbiota
Endocrinology 145:11941202 Sun Z, Li P, Wang X, Lai S, Qiu H, Chen Z, Hu S, Yao J, Shen J (2020) GLP-1/GLP-1R signaling regulates ovarian PCOS-associated granulosa cells proliferation and antiapoptosis by modification of forkhead box protein O1 phosphorylation sites
.png)
